AI Chip Boom Fuels Optimism, but Lam Research's High Valuation and China Risks Warrant Caution

What happened

Lam Research is targeting record Q4 sales of $6.6B, driven by AI-led demand in HBM, advanced DRAM, and leading-edge chips. The company's March quarter revenue of $5.84B already showed strong growth, but management itself warns China sales are likely to be materially and adversely affected by export licensing. With China representing 34-37% of revenue, any policy-driven decline could quickly offset AI tailwinds. At $433, the stock trades at a P/E of 81.5 and EV/EBITDA of 85.3, embedding an optimistic upcycle that leaves little room for error. A director's recent heavy selling further signals insiders may be taking advantage of elevated prices.

Implication

The bull case rests on sustained AI-driven WFE spending broadening beyond DRAM and China exposure remaining stable. However, the DeepValue report's bear scenario projects revenue stalling at $5.8B and margin compression if licensing cuts China share. The attractive entry point of $360 provides a 20% downside from current levels, offering a better margin of safety. Until the June quarter confirms both top-line momentum and China resilience, waiting on the sidelines is prudent. A break below $480 trim level would signal the start of a de-rating.

Thesis delta

The Zacks article reinforces the widely held AI narrative but does not alter the fundamental risk profile. The DeepValue report's WAIT rating remains appropriate, as elevated valuation and concentrated China exposure still outweigh positive demand signals. The key shift is that the upcoming Q4 result will test whether AI-driven demand can sustain record sales without a China-related setback.